Oral anticoagulation, aspirin, or no therapy in patients with nonvalvular AF with 0 or 1 stroke risk factor based on the CHA2DS2-VASc score.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Even a single additional stroke risk factor in patients with atrial fibrillation may confer a risk of stroke. However, there is no consensus on how best to treat these patients.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): J Am Coll Cardiol

Title: Journal of the American College of Cardiology

Publisher: Elsevier BV

ISSN (Electronic): 1558-3597

ISSN (Print): 0735-1097

Publication date (Electronic): Apr 14 2015

Volume: 65

Issue: 14

Affiliations

[1 ] Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Faculty of Health, Aalborg University, Aalborg, Denmark; University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham, United Kingdom. Electronic address: g.y.h.lip@bham.ac.uk.

[2 ] Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Faculty of Health, Aalborg University, Aalborg, Denmark; Department of Cardiology, AF Study Group, Aalborg University Hospital, Aalborg, Denmark.

[3 ] Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Faculty of Health, Aalborg University, Aalborg, Denmark.

Article

Publisher Item ID: S0735-1097(15)00433-7

DOI: 10.1016/j.jacc.2015.01.044

PubMed ID: 25770314

SO-VID: deb014f1-57ca-4566-9200-17404cb45af3

History

Keywords: atrial fibrillation,bleeding,stroke,thromboembolism,warfarin

Data availability:

Keywords: atrial fibrillation, bleeding, stroke, thromboembolism, warfarin

Comments

Comment on this article

scite_

Cited by 49

See all cited by

- Version 1
- Version 1